Total pages in book: 87
Estimated words: 82034 (not accurate)
Estimated Reading Time in minutes: 410(@200wpm)___ 328(@250wpm)___ 273(@300wpm)
Estimated words: 82034 (not accurate)
Estimated Reading Time in minutes: 410(@200wpm)___ 328(@250wpm)___ 273(@300wpm)
I watch fascinated, turned on, and even slightly horrified as Dane spreads the woman’s ass cheeks so he can pour lube. My heartrate accelerates as he starts to finger her ass… one finger, then two, and finally a third.
Holy shit. The woman writhes and cries out, completely having lost the ability to move on top of the other guy. No worries, he’s just fucking her from below by thrusting his cock inside her.
And then my throat goes dry as Dane lines the head of his condom-covered cock up to her ass, and slowly pushes his way in. There’s no working back and forth, moving in and out. He just pushes in, inch by inch of his huge cock disappearing inside the woman.
I feel my own ass pucker in abject sympathy. While I’m very curious as to what that feels like, I’m betting there’s quite a bit of pain with it.
Couldn’t tell by the woman’s face, though.
She’s groaning, chewing on her lip, eyes bright with passion as the two men dominate her. Both set up a rigorous pace within her body, and I stare in wonder at the cocks moving in and out of her.
A sudden image flashes before me, me sandwiched in between Andrew and Dane, and my sex actually spasms from the thought. The reaction of my body so surprises me that I’m jolted away from the carnal scene before me.
I spin around, my panties soaked and my need high.
I need to find someone to fuck and fast.
My eyes sweep the room and then lock on another man who is staring at me. He’s very handsome with dark red hair, a beard, and piercing blue eyes. He crooks a finger at me, and I can tell by the look on his face he knows I need something.
By the way he’s beckoning me to him, I know he can give it to me.
CHAPTER 8
Andrew
3 weeks later…
Fabron Lemaire sits across the table from me, calmly cutting into his steak while he goes right to the chase. Before he spears the piece, he glances right to Dane, left to Avril, then back to me because it’s my language he’s speaking.
“My imaging cytometer is unparalleled and FDA approved. I’m confident we can adapt it to your analyzer,” he says in his heavy French accent.
“We would need to run some initial tests,” I tell him, unwilling to commit anything based on just how well his patent has worked in standard hematology analyzers.
“I’m willing to do that,” he says with an affirming nod, “but I’d want my own scientists involved.”
I’m shaking my head before he can finish his demand. “Impossible. Everything is done in a sealed laboratory.”
“I’ll sign a non-disclosure,” he insists.
“We’re not about to let a competitive company into our labs to work on this. You wouldn’t want us poking around your secrets.”
“Then offer me a partnership,” Fabron says. By the gleam in his eye, I know this was top priority in this meeting.
My eyes slide to Dane, who looks amused as he sits back casually in his chair. Fabron turns to look at him as well. “Dane… you know my company’s reputation. My patent is solid. While I don’t understand the technology you’ve developed so far, I’m confident with the little you’ve told me that my cytometer is what you need to push forward with FDA approval.”
Dane leans forward and tells Fabron, “We’ve got our own people developing a cytometer. Why shouldn’t we just stick with that?”
Avril gives my leg a slight kick under the table, and I turn to look at her. I do this knowing I can tune Fabron and Dane out at this point. As the CEOs of their respective biotech companies, we’re getting close to the nitty gritty. When Fabron wants a partnership interest, it pulls it off my plate and puts it squarely on Dane’s.
Avril gives me a pointed look, and I can see the question in her eyes.
Will Dane bring this guy into the company?
I shrug and look back to Fabron as he extols his company’s virtues to Dane. Fabron is in his early fifties, but he looks about ten years younger. He got his education in the States and then went back to his home city of Paris to open Révéler Biotech, where he’s been pioneering the methodology for disease detection for his country.
“Well, why wouldn’t I want to partner with Caterva?” Fabron asks. “You’re one of the most talked about biotech firms in the world. Your board of directors consists of three U.S. senators, a five-star general, and a former secretary of state. The entire world has their eyes on Caterva because if your machine can be vetted and ultimately approved, you’re talking about changing the entire way the medical industry diagnoses disease. It’s worth billions.”
“Tell me something I don’t know,” Dane says with an easy laugh. He likes Fabron and had originally approached him to sit on the advisory board, but he couldn’t commit due to some other familial obligations he had going on at the time.